Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

therapeutic progesterone

The therapeutic form of the naturally occurring hormone progesterone. Progesterone binds to the progesterone receptor, resulting in dissociation of heat shock proteins, receptor phosphorylation, and transcription activation through direct or indirect interaction with transcription factors. This agent exerts inhibitory effects on estrogens by decreasing the number of estrogen receptors and increasing its metabolism to inactive metabolites. Progesterone induces secretory changes in the endometrium, decreases uterine contractility during pregnancy, and maintains pregnancy.
Synonym:progesterone
US brand name:Colprosterone
Lipo-Lutin
Luteohormone
Progestin
Prolutin
Proluton
Foreign brand name:Corlutina
Corluvite
Cyclogest
Gestiron
Gestone
Lutocyclin
Lutocylin
Lutocylin M
Lutogyl
Lutromone
Progestasert
Progesterol
Progestogel
Progestol
Progeston
Prolidon
Syngesterone
Utrogestan
Abbreviation:PRG
Chemical structure:17alpha-hydroxy-6alpha-methylpregn-4-ene-3,20-dione
delta4-pregnene-3,20-dione
NSC code:9704
Search NCI's Drug Dictionary